☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
US
AVITA Medical Launches Cohealyx for Wound Healing in the US
April 4, 2025
Organon Acquires Regulatory and Commercial Rights of Tofidence IV Infusion (Biosimilar, Actemra) from Biogen in the US
April 2, 2025
Zealand Pharma and Roche enter a ~$5.3B Deal to Co-Develop and Commercialize Petrelintide for Weight Management
March 12, 2025
Biocon Biologics Partners with Civica to extend access of Insulin Aspart in the US
March 7, 2025
Biocon Biologics Launches Yesintek (Biosimilar, Stelara) in the US
February 24, 2025
Alvotech and Teva Launch Selarsdi (Biosimilar, Stelara) in the US
February 24, 2025
Load more...
Back to Home
Modal title
×
Modal body text goes here.